UY36196A - Compuestos para usar en el tratamiento antihelmíntico - Google Patents

Compuestos para usar en el tratamiento antihelmíntico

Info

Publication number
UY36196A
UY36196A UY0001036196A UY36196A UY36196A UY 36196 A UY36196 A UY 36196A UY 0001036196 A UY0001036196 A UY 0001036196A UY 36196 A UY36196 A UY 36196A UY 36196 A UY36196 A UY 36196A
Authority
UY
Uruguay
Prior art keywords
compounds
treatment
antihelmintic
humans
animals
Prior art date
Application number
UY0001036196A
Other languages
English (en)
Inventor
Claudia Welz
Adeline Köhler
Kirsten Börngen
Ulrich Görgens
Hans-Georg Schwarz
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of UY36196A publication Critical patent/UY36196A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Abstract

Se describen compuestos de la fórmula (I) que poseen propiedades antihelmínticasen la que los elementos estructurales tienen el significado indicado en la descripción. Además se describen tales compuestos para el control, el tratamiento y/o la prevención de las infecciones con helmintos en animales y seres humanos
UY0001036196A 2014-07-25 2015-06-29 Compuestos para usar en el tratamiento antihelmíntico UY36196A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14178621 2014-07-25
EP15169965 2015-05-29

Publications (1)

Publication Number Publication Date
UY36196A true UY36196A (es) 2016-02-29

Family

ID=53610907

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036196A UY36196A (es) 2014-07-25 2015-06-29 Compuestos para usar en el tratamiento antihelmíntico

Country Status (14)

Country Link
US (1) US20170217931A1 (es)
EP (1) EP3172193A1 (es)
JP (1) JP2017521461A (es)
CN (1) CN107074803A (es)
AU (1) AU2015293966A1 (es)
BR (1) BR112017001384A2 (es)
CA (1) CA2955879A1 (es)
CL (1) CL2017000178A1 (es)
MX (1) MX2017001047A (es)
RU (1) RU2017105902A (es)
TW (1) TW201617330A (es)
UY (1) UY36196A (es)
WO (1) WO2016012485A1 (es)
ZA (1) ZA201701426B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7051703B2 (ja) 2016-04-15 2022-04-11 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ピラゾロピリミジン誘導体
US10357493B2 (en) 2017-03-10 2019-07-23 Selenity Therapeutics (Bermuda), Ltd. Metalloenzyme inhibitor compounds
BR112019028181A2 (pt) * 2017-06-30 2020-07-07 Bayer Animal Health Gmbh novos derivados de azaquinolina
EP3634959A1 (en) * 2017-08-04 2020-04-15 Bayer Animal Health GmbH Quinoline derivatives for treating infections with helminths

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI435863B (zh) 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd Ｎ-２-（雜）芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
US20110207771A1 (en) 2006-06-08 2011-08-25 Syngenta Crop Protection, Inc. N-(l-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
HUE029331T2 (en) 2007-04-12 2017-02-28 Nihon Nohyaku Co Ltd Worm-control agent for use in the preparation and method
WO2011020579A1 (de) 2009-08-20 2011-02-24 Bayer Cropscience Ag Verfahren zur herstellung von 1-phenyl-1,2,4-triazolen
KR101856577B1 (ko) * 2011-03-02 2018-05-10 고쿠리츠다이가쿠호우진 도쿄다이가쿠 내부 기생충 방제제
US20140256728A1 (en) 2011-11-02 2014-09-11 Bayer Intellectual Property Gmbh Compounds with nematicidal activity
PE20141996A1 (es) 2011-11-02 2014-11-28 Bayer Ip Gmbh Compuestos con actividad nematicida
EP2773631B1 (en) 2011-11-04 2015-09-09 Syngenta Participations AG Pesticidal compounds
US20140287916A1 (en) 2011-11-04 2014-09-25 Syngenta Participations Ag Pesticidal compounds
BR112014010133B1 (pt) 2011-11-04 2019-12-24 Syngenta Participations Ag composto pesticida, composição farmacêutica que compreende o composto pesticida e material de propagação de plantas tratado
JP2014532683A (ja) 2011-11-04 2014-12-08 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物
AU2012342433A1 (en) 2011-11-25 2014-06-12 Bayer Intellectual Property Gmbh Use of aryl and hetaryl carboxamides as endoparasiticides
TWI654180B (zh) * 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
AU2013310075A1 (en) 2012-08-30 2015-04-02 Nihon Nohyaku Co., Ltd. Endoparasite control agent and use thereof
EP2891492B1 (en) 2012-08-30 2022-11-09 The University of Tokyo Endoparasite control agent
TWI646092B (zh) * 2013-08-26 2019-01-01 拜耳作物科學股份有限公司 具有殺蟲活性之化合物

Also Published As

Publication number Publication date
BR112017001384A2 (pt) 2018-06-05
CA2955879A1 (en) 2016-01-28
US20170217931A1 (en) 2017-08-03
TW201617330A (zh) 2016-05-16
AU2015293966A1 (en) 2017-02-02
JP2017521461A (ja) 2017-08-03
MX2017001047A (es) 2017-10-12
RU2017105902A (ru) 2018-08-27
CL2017000178A1 (es) 2017-09-22
CN107074803A (zh) 2017-08-18
WO2016012485A1 (en) 2016-01-28
ZA201701426B (en) 2018-12-19
EP3172193A1 (en) 2017-05-31

Similar Documents

Publication Publication Date Title
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
NI201900070A (es) Compuestos heterocíclicos como inmunomoduladores
ECSP19003773A (es) Compuestos heterocíclicos como inmunomoduladores
CO2017004525A2 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
CL2017003404A1 (es) Compuestos antibacterianos
CL2016000424A1 (es) Métodos y composiciones para el arn-guiado tratamiento de la infección por vih
EA201692316A1 (ru) Производные холана для применения при лечении и/или профилактике fxr и tgr5/gpbar1-опосредованных заболеваний
CR20160456A (es) Compuestos de heteroarilo o arilo bibíclicos fusionados
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
CL2014001956A1 (es) Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas.
CR20150648A (es) Derivados de nucleósido 4´-azido, 3´-desoxi-3´-fluoro sustituido
UY35274A (es) Compuestos y métodos para tratar infecciones bacterianas
DOP2016000336A (es) Derivados de isoindolina para uso en el tratamiento de una infeccion viral
UY36221A (es) Derivados de isoindolinona
BR112018070497A2 (pt) métodos e formulações farmacêuticas para tratamento de condições oculares
DOP2018000066A (es) Compuestos útiles para inhibir ror-gamma-t
ES2965394T3 (es) Compuestos y composiciones para el tratamiento del cáncer
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2017000178A1 (es) Compuestos para usar en el tratamiento antihelmíntico
CL2018001493A1 (es) Nuevos derivados de fenilo
CR20150649A (es) Derivados de nucleósidos 4´-azido,3´-desoxi-3´-fluoro sustituido
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
CR20160529A (es) Composiciones farmacéuticas para tratar enfermedades infecciosas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220629